AI Startups

    Why Deep Tech Startups Keep Dying in India

    By ·

    Why Deep Tech Startups Keep Dying in India
    Nalini Nirad

    When Indian deep tech startups shut down, the default explanation is often technological failure. The reality, however, is far more uncomfortable. In many cases, the technology works. What breaks down is the ecosystem surrounding it.

    “Deep tech in India rarely fails because the technology is bad,” says Kushal Bhagia, founder and partner at All In Capital. “It fails because the environment around the technology is not ready.”

    Bhagia’s assessment goes to the heart of a structural problem that has persisted despite India’s ambitions in artificial intelligence, robotics, climate tech, and advanced manufacturing. While policy documents celebrate innovation and frontier technologies, founders operating on the ground encounter long sales cycles, misaligned capital, weak procurement pathways, and customers reluctant to be early adopters. By the time the ecosystem catches up, many startups have already run out of cash.

    Data from Tracxn show that at least 29 Indian deep-tech startups shut down in 2025, highlighting the sector’s fragility despite growing policy attention. The deadpool list spans AI infrastructure, energy storage, advanced materials, life sciences, robotics, and industrial technologies, with several firms founded between 2014 and 2019, indicating that longevity alone did not guarantee survival. 

    Energy and climate-linked technologies accounted for the largest share of closures, followed by AI-driven companies building core infrastructure rather than end applications. Most startups had no exits, no IPOs, and limited scale, indicating that many failed in the long gap between pilot validation and sustainable commercial adoption.

    The Market Isn’t Ready for the Lab

    For many deep tech founders, the initial assumption is that scientific or engineering risk is the biggest hurdle. In India, that assumption often proves wrong. According to Bhagia, the real risks lie in market readiness and adoption.

    “Enterprises here are careful buyers,” he explains. “They don’t adopt something just because it is innovative. They want proof, integration, service support, and continuity.”

    This caution translates into prolonged pilot phases. A startup may spend six months or longer running trials, customising deployments, and securing internal champions—all before a single cheque is written. During this time, the burn continues unabated. “A startup might have a great algorithm,” Bhagia says, “but if the customer needs six months of trials before writing a cheque, the company runs out of oxygen.”

    The problem is not a lack of innovation, but the absence of a buyer culture willing to take early risks. Unlike the US or China, where government contracts and large industrial buyers absorb early-stage uncertainty, Indian deep tech startups are often left negotiating with enterprises that treat innovation as optional rather than essential.

    Capital That Wants SaaS, Not Science

    If cautious customers are one pressure point, capital is another. Deep tech demands time, often years, to mature. Indian venture capital, however, remains structured for faster outcomes.

    “Deep tech needs time to mature, but early-stage funding in India expects consumer internet-style growth,” Bhagia notes.

    Fund cycles are shorter, cheque sizes are smaller, and investors frequently look for visible revenue within 18 to 24 months. That expectation forces founders building hardware, robotics, or core AI infrastructure to operate like SaaS companies, prioritising early revenue over reliability or robustness.

    The result is a distortion of incentives. Founders push products to market before they are fully ready, stretch themselves thin across custom deployments, or chase revenue that conceals deeper product weaknesses. When pilots fail to convert into repeatable sales, investor conviction begins to erode.

    “Conviction usually breaks when pilots don’t convert into repeatable revenue,” Bhagia says. “If every deployment feels custom, if sales cycles don’t shrink, that is a warning sign.”

    The Missing Middle: Where Startups Go to Die

    One of the least discussed, yet most lethal, gaps in India’s deep tech ecosystem is what Bhagia calls the “missing middle stage”. After securing an initial pilot, many startups need two or three more years to secure certifications, collect real-world data, and validate their products in industrial environments.

    “In other markets, there are programmes and strategic investors to cover that phase,” he explains. “In India, that bridge is thin, and a lot of good companies fall in that gap.”

    This gap is evident in the growing list of deep tech companies that shut down despite promising early traction. Without sustained capital or procurement support, founders are forced to either pivot prematurely or shut shop entirely.

    A Founder’s View from Failure

    Nazim Girach, Co-Founder of Glaucus Tech, offers a ground-level view of how these pressures play out. The startup, which operates in the warehousing and robotics space, did not fail because of a lack of technical capability. Instead, financial strain and market realities proved decisive.

    “We were not doing so great financially,” Girach recalls. “The going was a little tough market-wise.”

    One overlooked but critical factor was the founder's inexperience in managing cash flow. “Cash flow is a major reason companies go bust,” Girach says, noting that many first-time founders underestimate how quickly financial missteps compound.

    Market dynamics added further strain. Payment delays from mid-sized enterprises made already-thin margins unsustainable. “It was very tough to get good payment terms and payments on time,” he explains.

    Girach’s experience underscores a recurring theme in deep tech failures: even when the technology works and demand exists, the mechanics of selling, collecting payments, and sustaining day-to-day operations can quietly sink a company.

    India’s Price Sensitivity Problem

    For startups that survive the early years, pricing presents another structural challenge. Niharika Kolte, Founder and CEO of Volar Alta, points to India’s acute price sensitivity as a persistent constraint.

    “India is extremely price sensitive,” she says. “Cost-plus pricing doesn’t allow you to sustainably scale.”

    Volar Alta avoided an early collapse by starting with services, generating revenue while building a deep understanding of customer needs. Kolte says the company deliberately held back from building its AI platform until it had a detailed understanding of user pain points and value creation.

    “We didn’t start building our industrial AI platform until we had a super detailed understanding of the market,” she says.

    Crucially, international validation proved equally important. When doubts crept in, traction from customers from outside India reinforced that the problem was real and commercially meaningful.

    Execution is Harder Than the Prototype

    Another frequent failure point lies in execution. Translating research into a deployable, scalable product is fundamentally different from building a lab prototype.

    “Many teams underestimate how hard manufacturing, compliance, and customer support can be,” Bhagia warns.

    Girach echoes this from his hardware background, arguing that Indian deep tech founders often spend too long building in isolation, without sufficient customer feedback. “Co-developing solutions with customers really helps,” he says, adding that iteration cycles in India are painfully slow because of vendor dependencies and fragmented supply chains.

    Across both investor and founder perspectives, one message is consistent: technology alone does not build companies. “For me, the core question is simple,” Bhagia says. “Is the technology solving a real economic pain or just an impressive capability?”

    Deep tech startups often fail in India not because their ideas lack merit, but because they are launched into an ecosystem ill-equipped to support long gestation cycles, early risk-taking customers, or patient capital. The absence of targeted procurement, sustained funding bridges, and operational mentorship turns innovation into attrition.